ArticleThe Journal of clinical investigation2026

Osteopontin mediates acquired resistance to hypoxia-inducing antiangiogenics and promotes anti-PD-L1 refractoriness in breast cancer models.

Jose Luis Ruiz-Sepulveda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.